# A Study to Evaluate the Safety and Tolerability of Rituxan in Duchenne Muscular Dystrophy

> **NCT07475754** · NA · NOT_YET_RECRUITING · sponsor: **Peking Union Medical College Hospital** · enrollment: 5 (estimated)

## Conditions studied

- Duchenne Muscular Dystrophy (DMD)

## Interventions

- **DRUG:** Rituxan treatment

## Key facts

- **NCT ID:** NCT07475754
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-23
- **Primary completion:** 2026-05-30
- **Final completion:** 2027-04-23
- **Target enrollment:** 5 (ESTIMATED)
- **Last updated:** 2026-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07475754

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07475754, "A Study to Evaluate the Safety and Tolerability of Rituxan in Duchenne Muscular Dystrophy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07475754. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*